Picture of Integrated Diagnostics Holdings logo

IDHC — Integrated Diagnostics Holdings News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Integrated Diag Hdgs - Holding(s) in Company

RNS Number : 7094Z

Integrated Diagnostics Holdings PLC

08 April 2026

 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

JE00BLKGSR75

Issuer Name

INTEGRATED DIAGNOSTICS HOLDINGS PLC

UK or Non-UK Issuer

Non-UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

Actis LLP

City of registered office (if applicable)

London

Country of registered office (if applicable)

UK

4. Details of the shareholder

NameCity of registered officeCountry of registered office
Actis IDH LimitedSaint Peter PortGuernsey
5. Date on which the threshold was crossed or reached 31-Mar-2026 6. Date on which Issuer notified 08-Apr-2026 7. Total positions of person(s) subject to the notification obligation
% of voting rights attached to shares (total of 8.A)% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)Total of both in % (8.A + 8.B)Total number of voting rights held in issuer
Resulting situation on the date on which threshold was crossed or reached0.0000000.0000000.0000000
Position of previous notification (if applicable)
8. Notified details of the resulting situation on the date on which the threshold was crossed or reached 8A. Voting rights attached to shares
Class/Type of shares ISIN code(if possible)Number of direct voting rights (DTR5.1)Number of indirect voting rights (DTR5.2.1)% of direct voting rights (DTR5.1)% of indirect voting rights (DTR5.2.1)
GB00B65TLW28000.000000000
Sub Total 8.A00%
8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))
Type of financial instrumentExpiration dateExercise/conversion periodNumber of voting rights that may be acquired if the instrument is exercised/converted% of voting rights
Sub Total 8.B1
8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))
Type of financial instrumentExpiration dateExercise/conversion periodPhysical or cash settlementNumber of voting rights% of voting rights
Sub Total 8.B2
9. Information in relation to the person subject to the notification obligation 2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)
Ultimate controlling personName of controlled undertaking% of voting rights if it equals or is higher than the notifiable threshold% of voting rights through financial instruments if it equals or is higher than the notifiable thresholdTotal of both if it equals or is higher than the notifiable threshold
Actis LLP (chain 1)Actis GP LLP (as general partner of Actis Global 4 LP)0.0000000.0000000.000000%
Actis LLP (chain 1)Actis Global 4 LP0.0000000.0000000.000000%
Actis LLP (chain 1)Global 4 Sellco Limited0.0000000.0000000.000000%
Actis LLP (chain 1)IDH Issuerco Limited0.0000000.0000000.000000%
Actis LLP (chain 1)Actis IDH Limited (entity being disposed of)21.6700000.00000021.670000%
Actis LLP (chain 2)Actis GP LLP (as general partner of Actis Global 4A LP)0.0000000.0000000.000000%
Actis LLP (chain 2)Actis Global 4A LP0.0000000.0000000.000000%
Actis LLP (chain 2)Global 4 Sellco Limited0.0000000.0000000.000000%
Actis LLP (chain 2)IDH Issuerco Limited0.0000000.0000000.000000%
Actis LLP (chain 2)Actis IDH Limited (entity being disposed of)21.6700000.00000021.670000%
Actis LLP (chain 3)Actis GP LLP (as general partner of Actis Global 4C LP)0.0000000.0000000.000000%
Actis LLP (chain 3)Actis Global 4C LP0.0000000.0000000.000000%
Actis LLP (chain 3)Global 4 Sellco Limited0.0000000.0000000.000000%
Actis LLP (chain 3)IDH Issuerco Limited0.0000000.0000000.000000%
Actis LLP (chain 3)Actis IDH Limited21.6700000.00000021.670000%
Actis LLP (chain 4)Actis Guernsey GP Limited (as General partner of Actis 4 Co-Investment Scheme LP)0.0000000.0000000.000000%
Actis LLP (chain 4)Actis 4 Co-Investment Scheme LP0.0000000.0000000.000000%
Actis LLP (chain 4)Global 4 Sellco Limited0.0000000.0000000.000000%
Actis LLP (chain 4)IDH Issuerco Limited0.0000000.0000000.000000%
Actis LLP (chain 4)Actis IDH Limited (entity being disposed of)21.6700000.00000021.670000%
Actis LLP (chain 5)Actis GP LLP (as general partner of Actis Africa 4 LP)0.0000000.0000000.000000%
Actis LLP (chain 5)Actis Africa 4 LP0.0000000.0000000.000000%
Actis LLP (chain 5)Africa 4 Sellco Limited0.0000000.0000000.000000%
Actis LLP (chain 5)IDH Issuerco Limited0.0000000.0000000.000000%
Actis LLP (chain 5)Actis IDH Limited (entity being disposed of)21.6700000.00000021.670000%
Actis LLP (chain 6)Actis GP LLP (as general partner of Actis Africa 4A LP)0.0000000.0000000.000000%
Actis LLP (chain 6)Actis Africa 4A LP0.0000000.0000000.000000%
Actis LLP (chain 6)Africa 4 Sellco Limited0.0000000.0000000.000000%
Actis LLP (chain 6)IDH Issuerco Limited0.0000000.0000000.000000%
Actis LLP (chain 6)Actis IDH Limited21.6700000.00000021.670000%
10. In case of proxy voting Name of the proxy holder   The number and % of voting rights held   The date until which the voting rights will be held   11. Additional Information As announced on 13 November 2025 by Integrated Diagnostics Holdings plc (the "Company"), Actis GP LLP and Actis Guernsey GP Limited, each a subsidiary of Actis LLP and which through funds under their management control shares representing 21.67% of the Company (the "Actis Shareholding"), have agreed to dispose, by way of an indirect share sale of Actis IDH Limited, of the entire Actis Shareholding to a special purpose vehicle, the majority of which is controlled by funds managed by Elliott Investment Management L.P. (the "Transaction"). The Transaction, which at the time of the announcement was conditional on the receipt of regulatory clearance (which was received on 31 March 2026, at which point the transfer became unconditional), will settle on Thursday 9 April 2026.   12. Date of Completion 08-Apr-2026 13. Place Of Completion London, United Kingdom This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com. RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.   END     HOLUWSNRNWUSRAR

Recent news on Integrated Diagnostics Holdings

See all news